Trial Details
COMPLETEDBasic Information
| Clinical ID | c886 |
|---|---|
| Identifier | NCT03283085 |
| Trial Title | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease|Ulcerative Colitis |
| Interventions | DRUG: 25 mg Ontamalimab|DRUG: 75 mg Ontamalimab |
Participant Information
| Sponsor | Shire |
|---|---|
| City | Mesa |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-02-27 |
|---|---|
| Primary Completion Date | 2023-12-13 |
| Completion Date | 2023-12-13 |